Stay updated on Durvalumab Combo vs Chemo in Urothelial Cancer Clinical Trial
Sign up to get notified when there's something new on the Durvalumab Combo vs Chemo in Urothelial Cancer Clinical Trial page.

Latest updates to the Durvalumab Combo vs Chemo in Urothelial Cancer Clinical Trial page
- Check6 days agoChange DetectedThe footer revision label changed from v3.7.2 to v3.8.0, indicating a website software update.SummaryDifference0.0%

- Check13 days agoChange DetectedA banner announces NIH website transition updates and says NIH content may use “Super Intelligence” instead of “Artificial Intelligence” during the transition.SummaryDifference0.3%

- Check20 days agoChange DetectedThe site footer revision changed from v3.7.1 to v3.7.2.SummaryDifference0.0%

- Check27 days agoChange DetectedThe footer revision identifier changes from v3.7.0 to v3.7.1.SummaryDifference0.0%

- Check48 days agoChange DetectedThe history now shows Revision: v3.7.0, indicating a new version tag for the page. This is a version metadata update rather than a content change.SummaryDifference0.0%

- Check70 days agoChange DetectedA new revision entry, v3.6.6, was added to the study history. The previous revision, v3.6.5, was removed.SummaryDifference0.0%

Stay in the know with updates to Durvalumab Combo vs Chemo in Urothelial Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab Combo vs Chemo in Urothelial Cancer Clinical Trial page.